BERNARD L. KASTEN, M.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

ENZO BIOCHEM INC

Filing Date Source Excerpt
2009-12-23 Bernard L. Kasten has been a Director since January 2008 and serves on the Audit, Nominating and the Compensation Committees. Director compensation total $144,355.
2011-11-28 Bernard L. Kasten, M.D. has been a Director of the Company since January 2008 and currently serves on the Audit, Nominating/Governance and the Compensation Committees and since January 2011 serves as the Lead Independent Director and Chairman of the Compensation Committee.
2012-11-27 Bernard L. Kasten, M.D. has been a Director of the Company since January 2008 and currently serves on the Audit, Nominating/Governance and the Compensation Committees and since January 2011 serves as the Lead Independent Director and Chairman of the Compensation Committee. ... Director Compensation Table ... Barnard Kasten, MD. ... Total($) 149,000
2013-11-27 Bernard L. Kasten M.D. has been a Director of the Company since September 2008 and serves on the Audit, Nominating/Governance and the Compensation Committees and since January 2011 serves as the Lead Independent Director and Chairman of the Compensation Committee.
2014-11-26 Bernard L. Kasten M.D. has been a Director of the Company since September 2008 and serves on the Audit, Nominating/Governance and the Compensation Committees and since January 2011 serves as the Lead Independent Director and Chairman of the Compensation Committee. ... The following table sets forth the information concerning compensation earned during our fiscal year ended July 31, 2014 by all non-employee Directors: Bernard Kasten Total $176,618.
2016-11-23 Barnard L. Kasten, M.D. Lead Director Fees Earned or Paid in Cash $87,500, Restricted Stock/Stock Options Awards $104,304, Total $191,804. The Lead Independent Director receives an additional annual Director27s fee of $25,000. The Chairman of the Audit Committee receives an additional annual fee of $20,000 and the Chairman of the Compensation Committee and the Chairman of the Nominating and Corporate Governance Committee each receive an additional annual fee of $10,000.

Data sourced from SEC filings. Last updated: 2025-08-30